Ali Alkan
Impact in
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Oncology 14
- Cancer Diagnosis and Treatment 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Filiz Çay Şenler (10 shared papers)Hakan Akbulut (8 shared papers)Yüksel Ürün (6 shared papers)Özgür Tanrıverdi (18 shared papers)Stuart Walker (2 shared papers)Ahmet Demirkazık (5 shared papers)Hakan Ergün (1 shared paper)Güngör Utkan (9 shared papers)
- Journals
- Supportive Care in Cancer (4 papers)Future Oncology (2 papers)Frontiers in Pharmacology (2 papers)Journal of Oncology Pharmacy Practice (11 papers)International Journal of Gynecological Cancer (1 paper)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Ali Alkan
56 papers receiving 325 citations
Peers
Comparison fields: 5 of 83
- Geriatrics and Gerontology 41
- Applied Microbiology and Biotechnology 9
- Family Practice 8
- Ophthalmology 19
- Oncology 58
Countries citing papers authored by Ali Alkan
This map shows the geographic impact of Ali Alkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Alkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Alkan more than expected).
Fields of papers citing papers by Ali Alkan
This network shows the impact of papers produced by Ali Alkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Alkan. The network helps show where Ali Alkan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Alkan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 62 | |
| 2 | 2018 | 37 | |
| 3 | 2016 | 19 | |
| 4 | 2019 | 18 | |
| 5 | 2020 | 13 | |
| 6 | 2018 | 11 | |
| 7 | 2020 | 11 | |
| 8 | 2017 | 11 | |
| 9 | 2016 | 10 | |
| 10 | 2019 | 10 | |
| 11 | 2019 | 10 | |
| 12 | 2016 | 9 | |
| 13 | 2017 | 9 | |
| 14 | 2017 | 8 | |
| 15 | 2018 | 7 | |
| 16 | 2020 | 7 | |
| 17 | 2018 | 6 | |
| 18 | 2017 | 6 | |
| 19 | 2016 | 6 | |
| 20 | 2020 | 5 |
About Ali Alkan
Ali Alkan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pediatrics, Perinatology and Child Health and Economics and Econometrics, having authored 70 papers that have together received 332 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (5 papers), Pharmaceutical Economics and Policy (4 papers), Chemotherapy-related skin toxicity (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Cancer Diagnosis and Treatment (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Nutrition and Health in Aging (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Geriatrics and Gerontology (41 citations), Applied Microbiology and Biotechnology (9 citations), Family Practice (8 citations), Ophthalmology (19 citations) and Oncology (58 citations). Ali Alkan has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Filiz Çay Şenler, Hakan Akbulut, Yüksel Ürün, Özgür Tanrıverdi, Stuart Walker, Ahmet Demirkazık, Hakan Ergün, Güngör Utkan, Mehtap Honca and Çiğdem Soydal. Their work appears in journals such as Supportive Care in Cancer, Future Oncology, Frontiers in Pharmacology, Journal of Oncology Pharmacy Practice and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.